Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Phys Rev Lett ; 121(5): 053602, 2018 Aug 03.
Article in English | MEDLINE | ID: mdl-30118282

ABSTRACT

We report on observations of Ramsey interferences and spin echoes from electron spins inside a levitating macroscopic particle. The experiment is realized using nitrogen-vacancy (NV) centers hosted in a micron-sized diamond stored in a Paul trap both under atmospheric conditions and under vacuum. Spin echoes are used to show that the Paul trap preserves the coherence time of the embedded electron spins for more than microseconds. Conversely, the NV spin is employed to demonstrate high angular stability of the diamond even under vacuum. These results are significant steps towards strong coupling of NV spins to the rotational mode of levitating diamonds.

3.
Int J Parasitol ; 31(5-6): 523-31, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11334937

ABSTRACT

African trypanosomes escape the host immune response through a periodical change of their surface coat made of one major type of protein, the variant surface glycoprotein. From a repertoire of a thousand variant surface glycoprotein genes available, only one is expressed at a time, and this takes place in a specialised expression site itself selected from a collection of an estimated 20-30 sites. As the specialised expression sites are long polycistronic transcription units, the variant surface glycoprotein is co-transcribed with several other genes termed expression site-associated genes. How do the trypanosomes only use a single specialised expression site at a time? Why are there two dozen specialised expression sites? What are the functions of the other genes of these transcription units? We review the currently available answers to these questions.


Subject(s)
Antigenic Variation/genetics , Gene Expression Regulation/physiology , Trypanosoma brucei brucei/genetics , Variant Surface Glycoproteins, Trypanosoma/physiology , Animals , Antigenic Variation/immunology , Gene Expression Regulation/genetics , Gene Expression Regulation/immunology , Transcription, Genetic/genetics , Trypanosoma brucei brucei/immunology , Trypanosoma brucei brucei/metabolism , Variant Surface Glycoproteins, Trypanosoma/genetics , Variant Surface Glycoproteins, Trypanosoma/immunology
4.
Clin Diagn Lab Immunol ; 7(4): 607-11, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10882660

ABSTRACT

The potential of the dense granule antigens GRA1 and GRA6 of Toxoplasma gondii to be used as diagnosis reagents in a recombinant form was evaluated. Both proteins were expressed in Escherichia coli as glutathione-S-transferase (GST) fusions. The GST-GRA1 fusion comprises the entire GRA1 sequence devoid of its N-terminal signal peptide. Separate expression of the two N- and C-terminal hydrophilic regions of GRA6 showed that only the N-terminal hydrophilic part of the protein was recognized by a pool of positive human sera in an immunoblot. One hundred T. gondii-positive and 98 negative human sera were tested in two separate immunoglobulin G (IgG)-direct enzyme-linked immunosorbent assays (ELISAs) using either GST-GRA1 or GST-GRA6-Nt recombinant protein. Whereas the sensitivity of the GST-GRA1 IgG ELISA was low (68%), the GST-GRA6-Nt IgG ELISA reached a sensitivity of 96%. The reactivity to GRA6-Nt was shown to be high even with human sera of low IgG titers. In addition, comparison of the optical density values for each serum revealed that GRA1 may complement GRA6-Nt to reach an overall sensitivity of 98%. Therefore, the GST-GRA6-Nt ELISA could be used together with another antigen like GRA1 for the development of a recombinant antigen-based test for serodiagnosis of toxoplasmosis.


Subject(s)
Antibodies, Protozoan/analysis , Antibodies, Protozoan/immunology , Antigens, Protozoan/immunology , Protozoan Proteins/immunology , Toxoplasma/immunology , Toxoplasmosis/diagnosis , Toxoplasmosis/immunology , Animals , Antigens, Protozoan/genetics , Enzyme-Linked Immunosorbent Assay/methods , Humans , Immunoglobulin G/analysis , Immunoglobulin G/immunology , Protozoan Proteins/genetics , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Sensitivity and Specificity , Toxoplasma/genetics
5.
J Immunol ; 164(7): 3741-8, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10725733

ABSTRACT

Excreted-secreted Ags (ESA) of Toxoplasma gondii (Tg) play an important role in the stimulation of the host immune system in both acute and chronic infections. To identify the parasite Ag(s) involved in the maintenance of T cell-mediated long term immunity, 40 ESA-specific T cell clones were derived from three chronically infected healthy subjects. All the clones were CD4+ and recognized both ESA and live tachyzoites in a HLA-DR-restricted manner. Conversely, CD4+ tachyzoite-specific T cell clones from the same subjects proliferated in response to ESA, pointing to shared immunodominant Ags between ESA and Tg tachyzoites. By T cell blot analysis using SDS-PAGE-fractionated parasite extracts, the following patterns of reactivity were detected. Of 25 clones, 6 recognized Tg fractions in the 24- to 28-kDa range and proliferated to purified GRA2, 5 reacted with Tg fractions in the 30- to 33-kDa range; and 4 of them proved to be specific for rSAg1. Although surface Ag (SAg1) is not a member of ESA, small amounts of this protein were present in ESA preparation by Western blot. Of 25 clones, 8 responded to Tg fractions in the 50- to 60-kDa range but not to the 55-kDa recombinant rhoptries-2 parasite Ag, and 6 did not react with any Tg fraction but proliferated in response to either ESA or total parasite extracts. In conclusion, CD4+ T cells specific for either ESA (GRA2) or SAg1 may be involved in the maintenance of long term immunity to Tg in healthy chronically infected individuals.


Subject(s)
Antigens, Protozoan/immunology , Epitopes, T-Lymphocyte/immunology , Lymphocyte Activation/immunology , Protozoan Proteins/immunology , Protozoan Vaccines/immunology , T-Lymphocytes/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Animals , Antigens, Protozoan/genetics , Antigens, Protozoan/isolation & purification , Cell Communication/immunology , Chemical Fractionation , Chronic Disease , Clone Cells/immunology , Clone Cells/metabolism , Clone Cells/parasitology , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/genetics , Humans , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , Protozoan Proteins/genetics , Protozoan Proteins/isolation & purification , Protozoan Proteins/metabolism , Protozoan Vaccines/chemical synthesis , Protozoan Vaccines/genetics , T-Lymphocytes/metabolism , T-Lymphocytes/parasitology , Toxoplasma/growth & development , Toxoplasmosis/parasitology , Vaccines, Attenuated/chemical synthesis , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology , Vaccines, Synthetic/immunology
6.
Mol Biol Cell ; 10(4): 1277-87, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10198072

ABSTRACT

The intracellular parasite Toxoplasma gondii resides within a specialized compartment, the parasitophorous vacuole (PV), that resists fusion with host cell endocytic and lysosomal compartments. The PV is extensively modified by secretion of parasite proteins, including the dense granule protein GRA5 that is specifically targeted to the delimiting membrane of the PV (PVM). We show here that GRA5 is present both in a soluble form and in hydrophobic aggregates. GRA5 is secreted as a soluble form into the PV after which it becomes stably associated with the PVM. Topological studies demonstrated that GRA5 was inserted into the PVM as a transmembrane protein with its N-terminal domain extending into the cytoplasm and its C terminus in the vacuole lumen. Deletion of 8 of the 18 hydrophobic amino acids of the single predicted transmembrane domain resulted in the failure of GRA5 to associate with the PVM; yet it remained correctly packaged in the dense granules and was secreted as a soluble protein into the PV. Collectively, these studies demonstrate that the secretory pathway in Toxoplasma is unusual in two regards; it allows soluble export of proteins containing typical transmembrane domains and provides a mechanism for their insertion into a host cell membrane after secretion from the parasite.


Subject(s)
Protozoan Proteins/metabolism , Toxoplasma/physiology , Toxoplasma/pathogenicity , 3T3 Cells , Animals , Antigens, Protozoan/biosynthesis , Antigens, Protozoan/metabolism , Cells, Cultured , Cytoplasm/parasitology , Cytoplasmic Granules/physiology , Cytoplasmic Granules/ultrastructure , Fibroblasts/parasitology , Host-Parasite Interactions , Humans , Mice , Microscopy, Immunoelectron , Protozoan Proteins/biosynthesis , Protozoan Proteins/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Skin/parasitology , Toxoplasma/ultrastructure , Transfection , Vacuoles/physiology , Vacuoles/ultrastructure
7.
J Infect Dis ; 177(3): 746-53, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9498457

ABSTRACT

Toxoplasma gondii antigens are superantigens in mice. To investigate a superantigen effect in humans, lymphocytes from T. gondii-seronegative subjects were studied for proliferation to T. gondii antigens (TA). Marked cellular proliferation, predominantly of CD4+ lymphocytes, was apparent. TA elicited expansions of Vbeta-bearing lymphocytes in all subjects, but different Vbeta-bearing lymphocytes were expanded in different subjects in both CD4+ and CD8+ subpopulations. Cord blood cells also proliferated to TA. Previously fixed antigen-presenting cells were unable to present TA. Thus, T. gondii appears to produce a molecule(s) that induces polyclonal activation of human T cells and requires antigen processing to mediate this effect. That T. gondii does not appear to behave as a superantigen in humans is important in understanding the pathogenesis of T. gondii infection in immunocompromised hosts and in the design of anti-T. gondii vaccines.


Subject(s)
Antigens, Protozoan/immunology , T-Lymphocytes/immunology , Toxoplasma/immunology , Animals , Antigen-Presenting Cells/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cytotoxicity, Immunologic , Fetal Blood/cytology , Fetal Blood/immunology , Humans , Lymphocyte Activation , Receptors, Antigen, T-Cell, alpha-beta , Serologic Tests , Superantigens/immunology , T-Lymphocyte Subsets/immunology
8.
Mol Microbiol ; 21(2): 421-8, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8858595

ABSTRACT

Transient transformation of Toxoplasma using the CAT (chloramphenicol acetyl transferase) reporter gene has been used to map promoter elements of four genes encoding dense granule proteins (GRA1, GRA2, GRA5 and GRA6). Intense CAT activities (GRA1 > GRA5 > GRA2 > GRA6) are detected for constructs containing 379bp, 276bp, 209bp and 265bp upstream of the transcription start site of the GRA1, GRA2, GRA5 and GRA6 genes, respectively. Deletion analysis shows that optimal promoter activity of each gene is contained in the proximal region of the transcription start site: -129 to -47 for GRA1, -87 to -37 for GRA2, -156 to -30 for GRA5 and -146 to -27 for GRA6. Quantitative CAT assay and mutation analysis show that repeated motifs (A/TGAGACG) found in either orientation with respect to transcription are critical elements of these defined promoter regions. We have found such sequence elements in the upstream region of other Toxoplasma genes such as Tub1 and within the stretch of 27bp repeats of the SAG1 promoter.


Subject(s)
Genes, Protozoan , Toxoplasma/genetics , Animals , Base Sequence , Chloramphenicol O-Acetyltransferase/genetics , Chromosome Mapping , Consensus Sequence , DNA Primers/genetics , DNA, Protozoan/genetics , Gene Expression , Genes, Reporter , Molecular Sequence Data , Promoter Regions, Genetic , Protozoan Proteins/genetics , Repetitive Sequences, Nucleic Acid , Sequence Deletion , Transformation, Genetic
10.
Mol Biochem Parasitol ; 70(1-2): 85-94, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7637717

ABSTRACT

This work describes the molecular characterization of GRA6, a novel Toxoplasma gondii dense granule antigen of 32 kDa. cDNA clones encoding this protein were isolated using a rat serum directed against an HPLC fraction enriched in the protein GRA5. Cross-reactivity between GRA5 and GRA6 was demonstrated by production of sera against the recombinant GRA5 protein. A serum against a recombinant fragment of GRA6 which does not react with GRA5 allowed the localization of this antigen at the subcellular level. GRA6 is detected in the dense granules of tachyzoites, and in the parasitophorous vacuole, closely associated to the network. The gene encoding GRA6 and its flanking regions were completely sequenced from cDNA and genomic inserts. Primer extension experiments demonstrated that the cap site of the GRA6 gene was located 37 bp upstream of the 5' end of the longest cDNA insert (1600 bp). The GRA6 gene potentially encodes a 230-amino-acid polypeptide, does not contain any introns and seems to be present as a single copy in the genome of T. gondii. The deduced polypeptide contains two hydrophobic regions with the characteristics of transmembrane domains. The N-terminal domain does not fit the classical feature of a signal peptide. The central hydrophobic domain is flanked by two hydrophilic domains which contain four blocks of amino acids homologous to the GRA5 protein. The C-terminal hydrophilic region comprises 24% of glycine residues, which may indicate a structural role for GRA6 in the network.


Subject(s)
Antigens, Protozoan , Genes, Protozoan , Protozoan Proteins/isolation & purification , Toxoplasma/immunology , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Cross Reactions , Cytoplasmic Granules/chemistry , DNA, Complementary/genetics , Exons , Immune Sera , Mice , Microscopy, Immunoelectron , Molecular Sequence Data , Open Reading Frames , Peptide Fragments/immunology , Protein Structure, Tertiary , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Rats , Recombinant Fusion Proteins/immunology , Sequence Alignment , Sequence Homology, Amino Acid , Toxoplasma/genetics , Vacuoles/chemistry
11.
Appl Parasitol ; 34(4): 235-44, 1993 Nov.
Article in English | MEDLINE | ID: mdl-7507769

ABSTRACT

Two cDNA clones encoding the GRA2 (G.P.28.5) secreted antigen of Toxoplasma gondii were expressed in Escherichia coli as glutathione-S-transferase fusion polypeptides. A high level of expression was obtained for the first clone expressing the 59C-terminal amino acids of GRA2. The other one was an open-reading-frame of 212 amino acids containing the entire GRA2 cDNA. By ELISA, IgG antibodies directed against the 59aa recombinant polypeptide were detected in 33/44 (75%) sera from patients chronically infected with T. gondii and in 19/23 (82.6%) sera derived from patients with acute, primary toxoplasmosis. 10 of the 11 "chronic" sera which were negative by the 59aa ELISA were tested in a immunoblot against the 212aa open-reading-frame of GRA2: 8/10 were positive. A peptide representing the 15 C-terminal amino acids of GRA2 has been shown to contain the epitope recognized by a mouse monoclonal antibody (TG17-179). The reactivity of human sera with the 59aa recombinant polypeptide was inhibited to varying degrees when the sera were co-incubated with this peptide. Twelve chronic sera showed a range of inhibition from 8 to 100% and twelve acute sera an inhibition range of 15 to 90%. This suggests that the 15aa C-terminal peptide contains an epitope recognized in both the acute and chronic phases of infection and that other major epitope(s) exist in the 59aa C-terminal region of GRA2. As a conclusion, the recombinant GRA2 protein appears to contain at least three B-cell epitopes.


Subject(s)
Antigens, Protozoan/immunology , B-Lymphocytes/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Acute Disease , Animals , Antibodies, Protozoan/biosynthesis , Antibody Specificity , Antigens, Protozoan/genetics , Chronic Disease , Enzyme-Linked Immunosorbent Assay , Epitopes/analysis , Epitopes/genetics , Escherichia coli/genetics , Escherichia coli/metabolism , Humans , Immune Sera/immunology , Immunoblotting , Immunoglobulin A/analysis , Immunoglobulin G/biosynthesis , Immunoglobulin M/analysis , Recombinant Proteins/immunology , Sensitivity and Specificity , Toxoplasmosis/diagnosis
12.
Mol Biochem Parasitol ; 59(1): 143-53, 1993 May.
Article in English | MEDLINE | ID: mdl-8515776

ABSTRACT

The P21 antigen of Toxoplasma gondii, defined by the monoclonal antibody TG17-113, has been described as a dense granule component, secreted in the parasitophorous vacuole during host cell invasion. The present work reports the cloning of the gene encoding the P21 antigen, for which we propose the name GRA 5. A cDNA library was screened with a rat antiserum raised against an HPLC fraction enriched in the P21 antigen. cDNA clones encoding GRA 5 were selected by antibody selection on the recombinant proteins. All these clones were incomplete at the 5' end. The 5' fragment of the longest cDNA clone isolated by this first screening was used as a probe in secondary screenings of cDNA and genomic DNA libraries. A genomic fragment containing the P21 gene and nearly full-length cDNAs have been isolated and sequenced. The gene encoding GRA 5 is 834 bp long and does not contain any intron. The deduced amino acid sequence of an open reading frame encoding 133 amino acids perfectly matched that of 5 peptides microsequenced from the native antigen. A N-terminal hydrophobic region was found to possess the characteristics of a signal peptide of 25 amino acids. A second hydrophobic domain, bordered by two hydrophilic regions strongly suggests a transmembrane region. This molecular structure is supported by ultrastructural studies showing the association of the P21 antigen with the parasitophorous vacuole membrane.


Subject(s)
Antigens, Protozoan/genetics , Toxoplasma/genetics , Toxoplasma/immunology , Amino Acid Sequence , Animals , Antigens, Protozoan/metabolism , Base Sequence , Cloning, Molecular , Cytoplasmic Granules/immunology , Cytoplasmic Granules/ultrastructure , DNA, Protozoan/genetics , Genes, Protozoan , Intracellular Membranes/immunology , Intracellular Membranes/ultrastructure , Microscopy, Immunoelectron , Molecular Sequence Data , Toxoplasma/ultrastructure , Vacuoles/immunology , Vacuoles/ultrastructure
13.
Mol Biochem Parasitol ; 58(1): 71-82, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8384696

ABSTRACT

The monoclonal antibody (mAb) TG17.179 recognizes an excreted-secreted antigen (ESA) of 28.5 kDa named Gra 2, which is stored in the dense granules of Toxoplasma cells and secreted into the parasitophorous vacuole after host cell invasion. Screening of an expression cDNA library with TG17.179 led to the isolation of several clones, the longest one (clone L) being of 1030 bp. Clone L cDNA was found to be homologous to a previously described composite cDNA encoding a P28 protein of Toxoplasma gondii. Characterization of one genomic clone indicates that the complete GRA 2 gene is about 1.3 kb in length, including an intron of 241 bp. Northern blot and primer extension analyses confirmed the size of the mature messenger (1.1 kb). Amino acid partial sequencing of the native antigen purified by HPLC and metabolic radiolabelings of ESAs perfectly matched the primary amino acid structure deduced from the clone L cDNA. This primary translation product consists of an 185 amino acid polypeptide (19.8 kDa) including a 23 amino acid signal sequence. The presence of many serine and threonine residues may indicate an O-glycosylation. The predicted mature polypeptide shows an internal helical domain with 2 amphipathic alpha-helices. These might be involved in the association of Gra 2 with the membranous network within the parasitophorous vacuole.


Subject(s)
Antigens, Protozoan/genetics , Genes, Protozoan/genetics , Protozoan Proteins/genetics , Toxoplasma/genetics , Amino Acid Sequence , Animals , Antibodies, Protozoan/immunology , Antigens, Protozoan/immunology , Antigens, Protozoan/isolation & purification , Base Sequence , Exons/genetics , Gene Library , Inclusion Bodies/chemistry , Inclusion Bodies/immunology , Introns/genetics , Molecular Sequence Data , Protein Structure, Secondary , Protozoan Proteins/immunology , Protozoan Proteins/isolation & purification , Sequence Analysis, DNA , Toxoplasma/immunology , Toxoplasma/ultrastructure , Vacuoles/chemistry , Vacuoles/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...